Main competitors
Revenues (Y-1) Net Margin (Y-1) EBIT Margin (Y-1) ROE (Y-1) ROA (Y-1) Leverage (Y-1)
65.77L -534.72%-561.28% - - 0.18x
221.87Cr 36.99%-0.96%2.26%2.02%818.71x
537.62Cr 24.08%29.51%16.78%12.27%-0.97x
61Cr -210.54%-205.59%-249.28% - 0.72x
336.96Cr -39.59%-48.95%-4.4%-5.08%11x
255.86Cr 17.97%25.37%11.65%8.43%-0.66x
369.4Cr 25.89%28.63%20.56%12.29%-1.54x
29Cr -24.22%-26.28%-8.94%-4.69%-2.82x
26Cr -13.8%-7.18%-9.46%-9.11%18.95x
232.01Cr 33.73%37.59%35.53%27.02%-1.18x
96Cr -30.08%-31.31%-42.49% - 2.15x
11Cr -310.18%-226% - - -
24Cr -85.53%-78.53%-54.06%-26.62%-1.54x
83Cr -0.2%11.86%-0.5% - -6.61x
50Cr 32.27%31.52%16.33%13.74%-4x
8.8Cr -891.6%-695.44% - -54.35%0.77x
Average 146.43Cr -123.1% -107.32% -20.46% -2.19% 55.55x
Weighted average by Cap. 220.49Cr -55.93% -51.6% -29.02% 2.12% 144.77x
Bio Therapeutic Drugs
SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW